摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(-)-benzyl 6-[(3S,9S,14aR)-9-benzyl-6,6-dimethyl-1,4,7,10-tetraoxotetradecahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecin-3-yl]hexanoate | 286436-68-8

中文名称
——
中文别名
——
英文名称
(-)-benzyl 6-[(3S,9S,14aR)-9-benzyl-6,6-dimethyl-1,4,7,10-tetraoxotetradecahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecin-3-yl]hexanoate
英文别名
cyclo(-L-Asu(OBzl)-Aib-L-Phe-D-Pro-);cyclo[Aib-Phe-D-Pro-Asu(OBn)(OBn)];benzyl 6-[(3S,9S,12R)-3-benzyl-6,6-dimethyl-2,5,8,11-tetraoxo-1,4,7,10-tetrazabicyclo[10.3.0]pentadecan-9-yl]hexanoate
(-)-benzyl 6-[(3S,9S,14aR)-9-benzyl-6,6-dimethyl-1,4,7,10-tetraoxotetradecahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecin-3-yl]hexanoate化学式
CAS
286436-68-8
化学式
C33H42N4O6
mdl
——
分子量
590.72
InChiKey
NGKYPEULDYEUNH-GMQQYTKMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    43
  • 可旋转键数:
    11
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.48
  • 拓扑面积:
    134
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (-)-benzyl 6-[(3S,9S,14aR)-9-benzyl-6,6-dimethyl-1,4,7,10-tetraoxotetradecahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecin-3-yl]hexanoate 在 palladium on activated charcoal 、 三乙胺 盐酸羟胺氢气 、 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 1-羟基苯并三唑 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 反应 12.0h, 生成 cyclo [L-2-amino-8-hydroxyamide-suberoyl-aminoisobutyryl-L-phenylalanyl-D-prolyl]
    参考文献:
    名称:
    衣原霉素-异羟肟酸类似物作为组蛋白脱乙酰基酶抑制剂。
    摘要:
    根据衣原霉素和曲古抑菌素A的结构和HDAC抑制活性,设计并合成了衣原霉素-异羟肟酸类似物作为组蛋白脱乙酰基酶(HDAC)抑制剂。衣原霉素是环状四肽,在侧链中含有环氧酮部分,使其成为不可逆抑制剂。 HDAC。我们用异羟肟酸代替了衣原体的环氧酮部分,以设计有效且可逆的HDAC抑制剂。另外,对于一系列衣藻多菌素类似物系列,引入了许多氨基-环烷羧酸(Acc)而不是简单的氨基-异丁酸(Aib)。测试了所合成的化合物的HDAC抑制活性,结果表明其中许多是HDAC的有效抑制剂。用芳香族氨基酸代替衣原体的Aib残基增强了体内和体外的抑制活性。我们已经对衣原霉素-异羟肟酸类似物进行了圆二色性和分子模拟研究,并将其与衣原霉素的溶液结构进行了比较。
    DOI:
    10.1016/j.bmc.2004.08.041
  • 作为产物:
    参考文献:
    名称:
    Flexible Synthesis and Evaluation of Diverse Anti-Apicomplexa Cyclic Peptides
    摘要:
    A modular approach to synthesize anti-Apicomplexa parasite inhibitors was developed that takes advantage of a pluripotent cyclic tetrapeptide scaffold capable of adjusting appendage and skeletal diversities in only a few steps (one to three steps). The diversification processes make use of selective radical coupling reactions and involve a new example of a reductive carbon nitrogen cleavage reaction with SmI2. The resulting bioactive cyclic peptides have revealed new insights into structural factors that govern selectivity between Apicomplexa parasites such as Toxoplasma and Plasmodium and human cells.
    DOI:
    10.1021/jo4001492
点击查看最新优质反应信息

文献信息

  • CYCLIC PEPTIDES WITH AN ANTI-PARASITIC ACTIVITY
    申请人:Wong Yung-Sing
    公开号:US20120034593A1
    公开(公告)日:2012-02-09
    The present invention relates to a method for preparing a cyclic peptide with antiparasite activity and anticancer activity. The invention also relates to this peptide as an antiparasite agent, for example in the treatment of toxoplasmosis and as an anticancer agent. The invention also relates to the use of this cyclic peptide for treating organs ex vivo before transplantation.
    本发明涉及一种制备具有抗寄生虫活性和抗癌活性的环肽的方法。该发明还涉及将该肽作为抗寄生虫剂,例如在弓形虫病的治疗中以及作为抗癌剂的用途。该发明还涉及将该环肽用于移植前体外处理器官的用途。
  • Evaluation of functional groups on amino acids in cyclic tetrapeptides in histone deacetylase inhibition
    作者:Md. Shahidul Islam、Mohammed P. I. Bhuiyan、Md. Nurul Islam、Tienabe Kipassa Nsiama、Naoto Oishi、Tamaki Kato、Norikazu Nishino、Akihiro Ito、Minoru Yoshida
    DOI:10.1007/s00726-011-0947-6
    日期:2012.6
    The naturally occurring cyclic tetrapeptide, chlamydocin, originally isolated from fungus , consists of alpha-aminoisobutyric acid, -phenylalanine, -proline and an unusual amino acid ()-2-amino-8-(()-oxiran-2-yl)-8-oxooctanoic acid (Aoe) and inhibits the histone deacetylases (HDACs), a class of regulatory enzymes. The epoxyketone moiety of Aoe is the key functional group for inhibition. The cyclic tetrapeptide scaffold is supposed to play important role for effective binding to the surface of enzymes. In place of the epoxyketone group, hydroxamic acid and sulfhydryl group have been applied to design inhibitor ligands to zinc atom in catalytic site of HDACs. In the research for more potent HDAC inhibitors, we replaced the epoxyketone moiety of Aoe with different functional groups and synthesized a series of chlamydocin analogs as HDAC inhibitors. Among the functional groups, methoxymethylketone moiety showed as potent inhibition as the hydroxamic acid. On the contrary, we confirmed that borate, trifruoromethylketone, and 2-aminoanilide are almost inactive in HDAC inhibition.
  • PEPTIDES CYCLIQUES À ACTIVITÉ ANTIPARASITAIRE
    申请人:Universite Joseph Fourier (Grenoble 1)
    公开号:EP2417151B1
    公开(公告)日:2016-09-14
  • US9133237B2
    申请人:——
    公开号:US9133237B2
    公开(公告)日:2015-09-15
  • Flexible Synthesis and Evaluation of Diverse Anti-Apicomplexa Cyclic Peptides
    作者:Mariam Traoré、Flore Mietton、Danièle Maubon、Marine Peuchmaur、Flaviane Francisco Hilário、Rossimiriam Pereira de Freitas、Alexandre Bougdour、Aurélie Curt、Marjorie Maynadier、Henri Vial、Hervé Pelloux、Mohamed-Ali Hakimi、Yung-Sing Wong
    DOI:10.1021/jo4001492
    日期:2013.4.19
    A modular approach to synthesize anti-Apicomplexa parasite inhibitors was developed that takes advantage of a pluripotent cyclic tetrapeptide scaffold capable of adjusting appendage and skeletal diversities in only a few steps (one to three steps). The diversification processes make use of selective radical coupling reactions and involve a new example of a reductive carbon nitrogen cleavage reaction with SmI2. The resulting bioactive cyclic peptides have revealed new insights into structural factors that govern selectivity between Apicomplexa parasites such as Toxoplasma and Plasmodium and human cells.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物